GynAware Company

GynAware develops a pre-surgical biopsy for uterine myometrial tumours. 70% of women between the ages of 20 to 55 develop uterine fibroids. With healthcare providers lacking the tools to yield a diagnosis pre-surgically, many women do not receive the appropriate treatment that they require. GynAware is committed to bringing cutting-edge technology for clinicians in order to promote personalized care for patients. Thjey are building LeioGuide, the first hardware dedicated to the pre-surgical sampling of uterine muscle tumors.
Industry: Pelvic & Uterine Healthcare
Headquarters: Canada

Visit Website
Register and Claim Ownership